TrialJournal of child and adolescent psychopharmacology2014

Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.

Bjørn E Ramtvedt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.